MLN9708
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for MLN9708, covering 2017-11-13 to 2023-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06) [Phase 2]